Related Experiment Video
Updated: Mar 9, 2026
Identification of Functional Protein Regions Through Chimeric Protein Construction
Published on: January 8, 2019
Research Advances in Chemokine-like Factor Super Family Member 8
Deng-Hui Gao1, Hao Hu1, Zhi-Wei Fang1
1Department of Urology,Peking University People's Hospital,Beijing 100044,China.
Abstract:
Chemokine-like factor super family member (CMTM) is a novel generic family firstly reported by Peking University Center for Human Disease Genomics. CMTM8 is one member of this family and has exhibited tumor-inhibiting activities. It can encode proteins approaching to the transmembrane 4 superfamily. CMTM8 is down-regulated in most carcinoma cell lines and tissues. Over-expression of CMTM8 may inhibit the proliferation,migration,and invasion of carcinoma cells. However,the exact mechanism of its anti-tumor activity remains unclear. CMTM8 may be involved in various signaling pathways governing the occurrence and development of tumors. CMTM8 may be a new target in the gene therapies for tumors,while further studies on CMTM8 and its anti-tumor mechanisms are warranted.
Insights
Chemokine-like factor superfamily member 8 (CMTM8) shows tumor-inhibiting activity and is downregulated in cancers. Further research is needed to understand its anti-tumor mechanisms for potential gene therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chemokine-like factor superfamily member (CMTM) is a novel gene family.
- CMTM8, a member of this family, exhibits tumor-inhibiting activities.
- CMTM8 is frequently downregulated in various carcinoma cell lines and tissues.
Purpose of the Study:
- To investigate the anti-tumor role of CMTM8.
- To explore the potential of CMTM8 as a therapeutic target for cancer gene therapy.
Main Methods:
- Analysis of CMTM8 expression in carcinoma cell lines and tissues.
- Investigating the effects of CMTM8 overexpression on cancer cell proliferation, migration, and invasion.
Main Results:
- CMTM8 is downregulated in most carcinoma cell lines and tissues.
- Overexpression of CMTM8 may inhibit cancer cell proliferation, migration, and invasion.
- CMTM8's precise anti-tumor mechanisms and involvement in signaling pathways require further elucidation.
Conclusions:
- CMTM8 exhibits potential anti-tumor properties.
- CMTM8 may serve as a novel therapeutic target for cancer gene therapy.
- Further studies are warranted to fully understand CMTM8's anti-tumor mechanisms.
More Related Videos
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
01:21Chemotaxis and Direction of Cell Migration
01:31Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...